PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells

被引:62
作者
Cai, GF
Karni, A
Oliveira, EML
Weiner, HL
Hafler, DA
Freeman, GJ
机构
[1] Brigham & Womens Hosp, Dept Neurol, Lab Mol Immunol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
PD-1; ligand; costimulation; dendritic cells; human T cells; naive T cells; memory T cells; myelin basic protein;
D O I
10.1016/j.cellimm.2004.09.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We examined the role of the PD-1 pathway on the activation of naive, memory, and recently activated human CD4(+) T cells to test whether they responded differently. PD-1 ligand blockade modestly enhanced the percentage of responding T cells and production of IFN-gamma in a primary response to myelin basic protein (MBP) in normal donors. PD-1 ligand blockade strongly enhanced proliferation and cytokine production by memory or recently activated T cells (tetanus toxoid and MBP). Blockade of PD-L1 alone had more effect than PD-L2, consistent with its higher expression on ex vivo dendritic cells; furthermore, anti-PD-L1 plus anti-PD-L2 resulted in the greatest enhancement. Moreover, PD-L1-Ig inhibited anti-CD3 induced activation of naive, memory, and recently activated CD4+ T cells. Together, our data demonstrated PD-1 functioned as a negative regulatory pathway on naive T cells during a primary response, and more potently, on memory or recently activated T cells during a secondary response. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 44 条
[1]   Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].
Agata, Y ;
Kawasaki, A ;
Nishimura, H ;
Ishida, Y ;
Tsubata, T ;
Yagita, H ;
Honjo, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772
[2]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[3]   Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses [J].
Bennett, F ;
Luxenberg, D ;
Ling, V ;
Wang, IM ;
Marquette, K ;
Lowe, D ;
Khan, N ;
Veldman, G ;
Jacobs, KA ;
Valge-Archer, VE ;
Collins, M ;
Carreno, BM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :711-718
[4]   A two-step, two-signal model for the primary activation of precursor helper T cells [J].
Bretscher, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :185-190
[5]   Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production [J].
Brown, JA ;
Dorfman, DM ;
Ma, FR ;
Sullivan, EL ;
Munoz, O ;
Wood, CR ;
Greenfield, EA ;
Freeman, GJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1257-1266
[6]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[7]  
Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
[8]  
2-9
[9]   CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy [J].
Chambers, CA ;
Kuhns, MS ;
Egen, JG ;
Allison, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :565-594
[10]   SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation [J].
Chemnitz, JM ;
Parry, RV ;
Nichols, KE ;
June, CH ;
Riley, JL .
JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :945-954